Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: A double-blind, fixed-dosage, controlled trial

Boris Spivak*, Rael Strous, Ginette Shaked, Evgeny Shabash, Moshe Kotler, Avraham Weizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: A double-blind, fixed-dosage, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences